GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » COGS-to-Revenue

Halberd (Halberd) COGS-to-Revenue : 0.67 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd COGS-to-Revenue?

Halberd's Cost of Goods Sold for the six months ended in Jul. 2023 was $0.00 Mil. Its Revenue for the six months ended in Jul. 2023 was $0.00 Mil.

Halberd's COGS to Revenue for the six months ended in Jul. 2023 was 0.67.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Halberd's Gross Margin % for the six months ended in Jul. 2023 was 33.33%.


Halberd COGS-to-Revenue Historical Data

The historical data trend for Halberd's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd COGS-to-Revenue Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
COGS-to-Revenue
0.14 - 0.67

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
COGS-to-Revenue 0.14 - 0.67

Halberd COGS-to-Revenue Calculation

Halberd's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.002 / 0.003
=0.67

Halberd's COGS to Revenue for the quarter that ended in Jul. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.002 / 0.003
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Halberd's Gross Margin % for the six months ended in Jul. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.002 / 0.003
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Halberd COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Halberd's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236